申请人:Wyeth
公开号:US20040033988A1
公开(公告)日:2004-02-19
Compounds of the formula:
1
are useful in treating disease conditions mediated by TNF-&agr;, such as rheumatoid arthritis, osteoarthritis, sepsis, AIDS, ulcerative colitis, multiple sclerosis, Crohn's disease and degenerative cartilage loss.
公式为1的化合物在治疗由TNF-α介导的疾病条件中有用,例如类风湿性关节炎,骨关节炎,败血症,艾滋病,溃疡性结肠炎,多发性硬化症,克隆病和软骨退行性损失。